Uniphar (LON:UPR) Shares Down 2% - Here's What Happened

Key Points

• Shares fell 2% to GBX 348 (intraday low GBX 346) from a GBX 355 close, while volume surged to ~675,576 shares — a 522% increase over the average daily volume.
• The company shows high leverage with a debt-to-equity ratio of 159.99 and weak liquidity (quick ratio 0.60, current ratio 0.99), while trading at a market cap of £903.3M and a P/E of 17.85.
• Uniphar is a Dublin-based diversified healthcare services group serving more than 200 pharmaceutical and med-tech manufacturers across Commercial & Clinical, Product Access and Supply Chain & Retail divisions, with roughly 2,000 employees in Ireland, the UK and the Benelux.

Shares of Uniphar plc (LON:UPR - ) were down 2% during trading on Thursday . The company traded as low as GBX 346 and last traded at GBX 348. Approximately 675,576 shares traded hands during mid-day trading, an increase of 522% from the average daily volume of 108,675 shares. The stock had previously closed at GBX 355.

Uniphar Price Performance

The company has a debt-to-equity ratio of 159.99, a quick ratio of 0.60 and a current ratio of 0.99. The stock has a market cap of £903.32 million, a price-to-earnings ratio of 17.85 and a beta of 1.14. The business's fifty day simple moving average is GBX 344.66 and its 200 day simple moving average is GBX 331.50.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.